Ahrens Helmut, Steinicke Amelie Constanze, Gosheger Georg, Schwarze Jan, Bockholt Sebastian, Moellenbeck Burkhard, Theil Christoph
Department of Orthopedics and Tumor Orthopedics, Muenster University Hospital, Albert-Schweitzer-Campus 1, 48149 Muenster, Germany.
Antibiotics (Basel). 2024 Aug 15;13(8):771. doi: 10.3390/antibiotics13080771.
Increasing antibiotic resistance has been reported as an issue in the treatment of periprosthetic joint infection (PJI). A repeat two-stage revision for recurrent PJI is at high risk of reinfection. However, it is unclear if the microorganism profile plays a role with potentially more resistant or polymicrobial infections. This is a retrospective, single-center analysis of two-stage revisions performed between 2011 and 2017. We identified 46 patients who underwent a repeat resection arthroplasty for recurrent PJI of the same joint after a previous two-stage revision of the same joint at the same department. All microbiological findings were analyzed focusing on microbiological spectrum and resistance testing as well as the potential impact on reinfection-free survival. The most common organism found at the time of recurrent PJI were coagulase-negative (39%) followed by Gram-negative organisms (28%). The risk of polymicrobial infections, difficult-to-treat resistant organisms, and Gram-negative infections increased significantly. Among infections, there was a high percentage of methicillin-resistant species and resistance to oral antibiotics. Patients with Gram-negative organisms had a reduced infection-free survivorship, while resistant organisms were not associated with decreased survival. Patients who undergo a repeat two-stage revision for recurrent PJI have more polymicrobial and resistant organisms, although the impact on survivorship is unclear.
抗生素耐药性增加已被报道为人工关节周围感染(PJI)治疗中的一个问题。复发性PJI的两阶段翻修手术再次感染风险很高。然而,尚不清楚微生物谱是否在潜在的更具耐药性或多微生物感染中起作用。这是一项对2011年至2017年间进行的两阶段翻修手术的回顾性单中心分析。我们确定了46例患者,他们在同一科室对同一关节进行了前一次两阶段翻修后,因复发性PJI接受了再次切除关节成形术。所有微生物学结果均围绕微生物谱、耐药性检测以及对无再感染生存期的潜在影响进行分析。复发性PJI时最常见的病原体是凝固酶阴性菌(39%),其次是革兰氏阴性菌(28%)。多微生物感染、难治疗的耐药菌感染和革兰氏阴性菌感染的风险显著增加。在感染中,耐甲氧西林菌种和对口服抗生素耐药的比例很高。革兰氏阴性菌感染的患者无感染生存期缩短,而耐药菌与生存期降低无关。因复发性PJI接受再次两阶段翻修手术的患者有更多的多微生物和耐药菌,尽管对生存期的影响尚不清楚。